Skip to main content

Table 2 Statistical analysis of changes in Pru p 3 specific IgE and IgG4 levels after Pru p 3 immunotherapy

From: Pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with LTP syndrome

 

Median (Q1, Q3)

p-value

IgEa 0

6.51 (1.47, 21.70)

 

IgE 1

3.85 (1.08, 10.70)

 

IgE 3

4.69 (1.43, 8.76)

 

Dif IgE year 1-basal

− 1.12 (− 11.00, 0.17)

0.1269

Dif IgE year 3-basal

− 1.85 (− 6.90, 0.30)

0.0448

IgG4b 0

0.25 (0.10, 0.34)

 

IgG4 1

1.01 (0.29, 3.37)

 

IgG4 3

0.70 (0.24, 1.75)

 

Dif IgG4 year 1-basal

0.49 (0.04, 3.27)

0.0007

Dif IgG4 year 3-basal

0.43 (0.12, 1.30)

0.0004

  1. a IgE: KU/l
  2. b IgG: mg/l